Leo Pharma
Develops and supplies medicines for skin diseases and selected critical-care conditions to patients worldwide
Highlights
- New on EvolcAdded 2026-11-01
About Leo Pharma
LEO Pharma researches, develops, manufactures and supplies treatments for skin diseases. It also develops treatments in thrombosis and immunooncology.
The company serves patients through a global presence spanning more than 70 countries. It was established in Denmark in 1908 and has manufacturing sites in Denmark, Ireland, France and Italy.
LEO Pharma Oy is registered in Vantaa, Finland. The company lists offices and entities across Europe, the Americas, Asia, the Middle East and Oceania.
Product: Medicines for skin diseases, thrombosis and rare cancers.
Public tenders won
3 tenders won since 1 Jan 2024 from 2 public buyers in Finland, worth €198.0M as awarded. From EU award notices (TED) that name Leo Pharma by its registry number.
- 8 Sep 2026 Pohjois-Pohjanmaan hyvinvointialue · Lääkevalmisteet ja niihin rinnastettavat tuotteet hankintakaudelle 1.1.2026-31.12.2027 · €142 notice
- 26 May 2025 Sansia Oy · Lääkkeiden erillishankinnat Itä-Suomen yhteistyöalueelle · €68.0M notice
- 12 Apr 2024 Sansia Oy · Lääkevalmisteet sekä niihin rinnastettavat valmisteet Itä-Suomen yhteistyöalueelle · €130.0M notice
Jobs at Leo Pharma
Leadership
- Christophe Bourdon · CEO, LEO PharmaSource: company website
- Philip Eickhoff · Chief Financial Officer and Executive Vice President, Global Finance and Business ServicesSource: company website
- Helle Hedegaard Juhl · Executive Vice President, Global People & Corporate AffairsSource: company website
More biotech & pharma companies
LignoSphere Company
Colloidal lignin particles from kraft lignin for coating and adhesive manufacturers seeking fossil-free phenolic substitutesYoung companyNew on EvolcLinio Biotech
Regenerative tissue platform (Tience) for skin and soft-tissue defect treatment, used by clinicians in the NordicsNew on EvolcMedicortex Finland
Develops biomarker-based diagnostic tests for traumatic brain injury and concussionNew on EvolcMediteema
Medical and pharmacovigilance expert services for pharma companies, medical device makers and CROsNew on EvolcMediwest Research Center
Administrative, legal and financial services for clinical pharmaceutical research at Finnish central hospitalsNew on EvolcMisvik Biology
Cancer drug screening and preclinical research services for biopharma companies and academic institutionsNew on Evolc
Website technologies
Tools and platforms detected on this company’s website, grouped by purpose. Dates record when Evolc observed them.
Content management
- WordPressHigh confidence
- First detected
- Last detected
- Last checked
Detection evidence
- Website resourcedeclared script/iframe or software asset
Forms
- Google reCAPTCHAHigh confidence
- First detected
- Last detected
- Last checked
Detection evidence
- Website resourcedeclared script/iframe or software asset
Frontend frameworks
- ReactHigh confidence
- First detected
- Last detected
- Last checked
Detection evidence
- Website resourcedeclared script/iframe or software asset
Hosting
- AzureMedium confidence
- First detected
- Last detected
- Last checked
Detection evidence
- Page markupsoftware structure signature
- nginxHigh confidence
- First detected
- Last detected
- Last checked
Detection evidence
- Response headerserver
- Response headerserver
- Response headerserver
Monitoring
- New RelicMedium confidence
- First detected
- Last detected
- Last checked
Detection evidence
- Integration code on pageinitialization/configuration expression
Privacy & consent
- Cookie InformationHigh confidence
- First detected
- Last detected
- Last checked
Detection evidence
- Website resourcedeclared script/iframe or software asset
Website detection does not establish a paid subscription or company-wide use. Tools loaded after consent or sign-in may be missed. “No longer observed” does not prove the company stopped using a tool.